Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease.

Eisdorfer C, Cohen D, Paveza GJ, Ashford JW, Luchins DJ, Gorelick PB, Hirschman RS, Freels SA, Levy PS, Semla TP, et al.

Am J Psychiatry. 1992 Feb;149(2):190-4. Erratum in: Am J Psychiatry 1992 Aug;149(8):1129.

PMID:
1734738
2.

Empirical evaluation of the global deterioration scale for staging Alzheimer's disease.

Reisberg H, Ferris SH, Sclan SG.

Am J Psychiatry. 1993 Apr;150(4):680-2. No abstract available.

PMID:
8465902
3.
4.

The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease.

Byrne LM, Wilson PM, Bucks RS, Hughes AO, Wilcock GK.

Int J Geriatr Psychiatry. 2000 Jul;15(7):656-61.

PMID:
10918348
5.

Personality changes in Alzheimer's disease.

Bózzola FG, Gorelick PB, Freels S.

Arch Neurol. 1992 Mar;49(3):297-300.

PMID:
1536633
6.

Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.

Na HR, Kim SY, Chang YH, Park MH, Cho ST, Han IW, Kim TY, Hwang SA.

J Alzheimers Dis. 2010;22(1):151-8. doi: 10.3233/JAD-2010-100072.

PMID:
20847407
7.

The Global Deterioration Scale for assessment of primary degenerative dementia.

Reisberg B, Ferris SH, de Leon MJ, Crook T.

Am J Psychiatry. 1982 Sep;139(9):1136-9.

PMID:
7114305
8.

The construct of minor and major depression in Alzheimer's disease.

Starkstein SE, Jorge R, Mizrahi R, Robinson RG.

Am J Psychiatry. 2005 Nov;162(11):2086-93.

PMID:
16263848
9.

Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.

Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F; ROSA Study Group..

Int J Geriatr Psychiatry. 2013 Feb;28(2):164-72. doi: 10.1002/gps.3805. Epub 2012 Apr 11.

PMID:
22492589
10.

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.

PMID:
12535396
11.

[Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].

Pákáski M, Drótos G, Janka Z, Kálmán J.

Orv Hetil. 2012 Mar 25;153(12):461-6. doi: 10.1556/OH.2012.29332. Hungarian.

PMID:
22411219
12.

A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.

Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T.

Am J Psychiatry. 2003 May;160(5):857-66.

PMID:
12727688
13.

[Correlations between cognition and function in Alzheimer's disease: based on the abbreviated Barcelona Test (a-BT)].

Peña-Casanova J, Monllau A, Böhm P, Blesa González R, Aguilar Barberà M, Sol JM, Hernández G; Grupo NORMACODEM..

Neurologia. 2005 Jan-Feb;20(1):4-8. Spanish.

PMID:
15704015
14.

The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S51-6.

PMID:
9236953
15.

Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis.

Ippen CG, Olin JT, Schneider LS.

Am J Geriatr Psychiatry. 1999 Fall;7(4):321-30.

PMID:
10521165
16.

[The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia].

Krzymińska E, Rossa G, Krzymiński S.

Psychiatr Pol. 1993 Mar-Apr;27(2):129-38. Polish.

PMID:
8378466
17.

Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.

Dukoff R, Sunderland T.

Am J Psychiatry. 1997 Aug;154(8):1070-5.

PMID:
9247391
18.

A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.

Weiner MF, Koss E, Patterson M, Jin S, Teri L, Thomas R, Thal LJ, Whitehouse P.

J Psychiatr Res. 1998 Nov-Dec;32(6):347-51.

PMID:
9844950
19.

Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.

Cullum CM, Saine K, Chan LD, Martin-Cook K, Gray KF, Weiner MF.

Neuropsychiatry Neuropsychol Behav Neurol. 2001 Apr-Jun;14(2):103-8.

PMID:
11417663
20.

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R; Texas Alzheimer's Research Consortium..

Arch Neurol. 2008 Aug;65(8):1091-5. doi: 10.1001/archneur.65.8.1091.

Supplemental Content

Support Center